Valuation as at 2026-08-14 · see also the Europe Most Undervalued screen
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities.
Source: Yahoo Finance company profile · factual description, not KashVector commentary
Siemens Healthineers AG SHL.DE
Healthcare · Medical Devices
Siemens Healthineers AG's price & financial trends
Each card is labelled with its own reporting period — quarterly where Yahoo provides it for this market, annual otherwise.
Data as at 2026-08-14
Share price · last 2 years
Earnings per share (diluted) Per quarter
Free cash flow Per quarter
Dividend per share Per year
Value investing scale · Buffett · Dalio · Graham
Intrinsic value estimate · 5-year forecast
Assumptions used in this valuation
Every input below is either fetched live from Yahoo Finance or a documented default — nothing is hidden.
| Bear | Base | Bull | |
|---|---|---|---|
| 5-yr FCF growth | 6.0% | 12.1% | 18.1% |
| Terminal growth | 1.8% | 1.8% | 1.8% |
| WACC (discount rate) | 7.64% | 6.64% | 5.64% |
Cost of Equity = Risk-free rate + Beta × Equity Risk Premium = 3.20% + 0.83 × 5.50% = 7.76% · WACC = weighted by 74%/26% capital structure
These numbers come from running Siemens Healthineers AG's cash flows through the mechanical DCF formula and assumptions above — not from any view on the news, management, or SHL.DE's competitive position. What is DCF?
Want to test your own growth or discount-rate assumptions?Open the full interactive calculator, pre-filled with SHL.DE →
More stocks we've valued
Not financial advice. DCF valuations are highly sensitive to assumptions — small changes in growth rate or discount rate produce large swings in output. This is a mechanical calculation, not a recommendation to buy, hold, or sell.
About this valuation
Computed on 2026-08-14 from Yahoo Finance data, using the same engine as the full DCF tool and the Europe Most Undervalued screen. Every figure above is a point-in-time snapshot of that date — change any assumption yourself in the interactive tool for a live one.
Frequently asked questions
Is Siemens Healthineers AG (SHL.DE) undervalued?
The Base-case DCF estimates intrinsic value at €51.36 vs a price of €39.04 on 2026-08-14 — a +31.6% margin, so the Base case reads undervalued. This is a mechanical output, not advice.